The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2004;351(10):1038.

Correspondence
PreviousPrevious
Volume 350:2096-2099 May 13, 2004 Number 20
NextNext

High-Bone-Mass Disease and LRP5

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
-Related Article
 by Boyden, L. M.
-PubMed Citation
To the Editor: Boyden et al. (May 16, 2002, issue)1 report cosegregation of a syndrome of high bone density, jaw enlargement, and torus palatinus with a missense mutation — a G-to-T substitution at position 512, encoding a glycine-to-valine substitution at amino acid residue 171 (G171V) — in the gene encoding low-density lipoprotein receptor–related protein 5 (LRP5). This autosomal dominant condition seemed benign, enhancing skeletal mass without causing complications of osteopetrosis. Genealogic studies showed no relationship with the healthy kindred with high bone mass described in 1997 by Johnson et al.2 and documented as having the identical LRP5 V171 mutation . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.